A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

NCT05552157 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Alzheimers Disease
Dementia
Alzheimers Disease, Familial

Interventions

DRUG: Remternetug (SC)
DRUG: Matching Placebo (Remternetug)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]